{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:55:28Z","timestamp":1763747728341,"version":"3.41.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.steroids.2017.10.006","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T15:03:23Z","timestamp":1508771003000},"page":"32-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis"],"prefix":"10.1016","volume":"128","author":[{"given":"Shima","family":"Dokoohaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Ghareghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Ghanbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naser","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Zibara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heibatollah","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 7","key":"10.1016\/j.steroids.2017.10.006_b0005","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awq076","article-title":"Evidence for a two-stage disability progression in multiple sclerosis","volume":"133","author":"Leray","year":"2010","journal-title":"Brain J. Neurol."},{"issue":"2","key":"10.1016\/j.steroids.2017.10.006_b0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1212\/WNL.36.2.238","article-title":"High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations","volume":"36","author":"Durelli","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.steroids.2017.10.006_b0015","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/B978-0-444-52001-2.00020-0","article-title":"Glucocorticoid treatment of multiple sclerosis","volume":"122","author":"Goodin","year":"2014","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.steroids.2017.10.006_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.psychres.2007.11.022","article-title":"The association of nocturnal serum melatonin levels with major depression in patients with acute multiple sclerosis","volume":"161","author":"Akpinar","year":"2008","journal-title":"Psychiatry Res."},{"issue":"Suppl 2","key":"10.1016\/j.steroids.2017.10.006_b0025","first-page":"S180","article-title":"The Role of Melatonin in the pathogenesis of multiple sclerosis: a case-control study","volume":"4","author":"Ghorbani","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.steroids.2017.10.006_b0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0079-6123(08)81008-4","article-title":"Melatonin: a multitasking molecule","volume":"181","author":"Reiter","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"6","key":"10.1016\/j.steroids.2017.10.006_b0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/smrv.2000.0127","article-title":"Treatment of sleep disturbance in Alzheimer\u2019s disease","volume":"4","author":"McCurry","year":"2000","journal-title":"Sleep Med. Rev."},{"issue":"9","key":"10.1016\/j.steroids.2017.10.006_b0040","doi-asserted-by":"crossref","first-page":"16848","DOI":"10.3390\/ijms150916848","article-title":"Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways","volume":"15","author":"Jenwitheesuk","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.steroids.2017.10.006_b0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbi.2015.06.021","article-title":"Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector\/regulatory balance","volume":"50","author":"Alvarez-Sanchez","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.steroids.2017.10.006_b0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.intimp.2015.12.020","article-title":"Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of experimental autoimmune encephalomyelitis","volume":"31","author":"Chen","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.steroids.2017.10.006_b0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/1440-1681.12678","article-title":"Melatonin exacerbates acute experimental autoimmune encephalomyelitis by enhancing the serum levels of lactate: a potential biomarker of multiple sclerosis progression","volume":"44","author":"Ghareghani","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2\u20133","key":"10.1016\/j.steroids.2017.10.006_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-5728(92)90142-8","article-title":"The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis","volume":"40","author":"Frequin","year":"1992","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.steroids.2017.10.006_b0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.55782\/ane-1996-1138","article-title":"Functional connections between the pineal gland and immune system","volume":"56","author":"Skwarlo-Sonta","year":"1996","journal-title":"Acta Neurobiol. Exp."},{"issue":"1\u20132","key":"10.1016\/j.steroids.2017.10.006_b0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1014833030530","article-title":"Effect of stress and dexamethasone treatment on circadian rhythms of melatonin and corticosterone in ring dove (Streptopelia risoria)","volume":"232","author":"Barriga","year":"2002","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.steroids.2017.10.006_b0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-079X.1988.tb00657.x","article-title":"Influence of dexamethasone on nocturnal melatonin production in healthy adult subjects","volume":"5","author":"Demisch","year":"1988","journal-title":"J. Pineal Res."},{"issue":"3","key":"10.1016\/j.steroids.2017.10.006_b0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/acta.0.1110355","article-title":"Serum melatonin is not affected by glucocorticoid replacement in congenital adrenal hyperplasia","volume":"111","author":"Waldhauser","year":"1986","journal-title":"Acta Endocrinol."},{"issue":"Pt 7","key":"10.1016\/j.steroids.2017.10.006_b0085","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/brain\/123.7.1431","article-title":"T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy","volume":"123","author":"Schmidt","year":"2000","journal-title":"Brain J. Neurol."},{"issue":"1 Suppl","key":"10.1016\/j.steroids.2017.10.006_b0090","first-page":"77","article-title":"Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury","volume":"93","author":"Kaptanoglu","year":"2000","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.steroids.2017.10.006_b0095","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.biopha.2016.11.042","article-title":"Methylprednisolone improves lactate metabolism through reduction of elevated serum lactate in rat model of multiple sclerosis","volume":"84","author":"Ghareghani","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1\u20132","key":"10.1016\/j.steroids.2017.10.006_b0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-4347(98)00182-0","article-title":"High-performance liquid chromatographic analysis of melatonin in human plasma and rabbit serum with on-line column enrichment","volume":"712","author":"Bechgaard","year":"1998","journal-title":"J. Chromatogr. B: Biomed. Sci. Appl."},{"issue":"1","key":"10.1016\/j.steroids.2017.10.006_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.steroids.2017.10.006_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0169-328X(97)00106-X","article-title":"Tissue-specific glucocorticoid regulation of tryptophan hydroxylase mRNA levels","volume":"48","author":"Clark","year":"1997","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3759","key":"10.1016\/j.steroids.2017.10.006_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.155.3759.217","article-title":"Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor","volume":"155","author":"Lovenberg","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.steroids.2017.10.006_b0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2014.10.003","article-title":"Melatonin ameliorates dexamethasone-induced inhibitory effects on the proliferation of cultured progenitor cells obtained from adult rat hippocampus","volume":"145","author":"Ekthuwapranee","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.steroids.2017.10.006_b0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jir.1990.10.403","article-title":"Interferon-gamma modulates melatonin production in rat pineal glands in organ culture","volume":"10","author":"Withyachumnarnkul","year":"1990","journal-title":"J. Interferon Res."},{"issue":"1","key":"10.1016\/j.steroids.2017.10.006_b0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-079X.1997.tb00300.x","article-title":"Nocturnal changes in pineal melatonin synthesis during puberty: relation to estrogen and progesterone levels in female rats","volume":"22","author":"Okatani","year":"1997","journal-title":"Journal of Pineal Research"},{"issue":"4","key":"10.1016\/j.steroids.2017.10.006_b0135","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1600-079X.1998.tb00537.x","article-title":"Estrogen modulates the nocturnal synthesis of melatonin in peripubertal female rats","volume":"24","author":"Okatani","year":"1998","journal-title":"J. Pineal Res."},{"issue":"2","key":"10.1016\/j.steroids.2017.10.006_b0140","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-079X.1999.tb00598.x","article-title":"Changes in nocturnal pineal melatonin synthesis during the perimenopausal period: relation to estrogen levels in female rats","volume":"27","author":"Okatani","year":"1999","journal-title":"J. Pineal Res."},{"issue":"7","key":"10.1016\/j.steroids.2017.10.006_b0145","first-page":"401","article-title":"The effect of estradiol on the production of melatonin in postmenopausal women","volume":"33","author":"Bartsch","year":"1995","journal-title":"Int. J. Clin. Pharmacol. Therap."},{"issue":"1","key":"10.1016\/j.steroids.2017.10.006_b0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03348377","article-title":"Effect of estradiol on plasma melatonin levels","volume":"7","author":"Penny","year":"1984","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"10.1016\/j.steroids.2017.10.006_b0155","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/art.21984","article-title":"Population-based assessment of adverse events associated with long-term glucocorticoid use","volume":"55","author":"Curtis","year":"2006","journal-title":"Arthritis Care Res."},{"issue":"6890","key":"10.1016\/j.steroids.2017.10.006_b0160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1136\/bmj.306.6890.1477-d","article-title":"Sleep disorders. Steroids cause sleep disturbance","volume":"306","author":"Turner","year":"1993","journal-title":"Br. Med. J."},{"issue":"2","key":"10.1016\/j.steroids.2017.10.006_b0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.51.2.285","article-title":"Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects","volume":"51","author":"Lyons","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.steroids.2017.10.006_b0170","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0306-4530(02)00085-9","article-title":"Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis","volume":"28","author":"Antonijevic","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.steroids.2017.10.006_b0175","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1365-2826.2003.00989.x","article-title":"Role of melatonin in the regulation of human circadian rhythms and sleep","volume":"15","author":"Cajochen","year":"2003","journal-title":"J. Neuroendocrinol."},{"issue":"1\u20132","key":"10.1016\/j.steroids.2017.10.006_b0180","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2011.11.003","article-title":"Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis","volume":"314","author":"Melamud","year":"2012","journal-title":"J. Neurol. Sci."},{"issue":"3\u20134","key":"10.1016\/j.steroids.2017.10.006_b0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/00207459308994277","article-title":"Multiple sclerosis: the role of puberty and the pineal gland in its pathogenesis","volume":"68","author":"Sandyk","year":"1993","journal-title":"Int. J. Neurosci."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:26:59Z","timestamp":1750958819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X17301861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"alternative-id":["S0039128X17301861"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2017.10.006","relation":{},"ISSN":["0039-128X"],"issn-type":[{"type":"print","value":"0039-128X"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroid therapy exacerbates the reduction of melatonin in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2017.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}